Michael B. Chancellor - 13 Mar 2024 Form 4 Insider Report for LIPELLA PHARMACEUTICALS INC. (LIPO)

Role
Chief Medical Officer, Director, 10%+ Owner
Signature
/s/ Michael B. Chancellor
Issuer symbol
LIPO
Transactions as of
13 Mar 2024
Net transactions value
+$100,000
Form type
4
Filing time
15 Mar 2024, 12:19:19 UTC
Previous filing
21 Jun 2023
Next filing
19 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIPO Common Stock Award $100,000 +144,906 +20% $0.6901 877,637 13 Mar 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The number of shares of Common Stock has been increased by one from the number of shares reported as directly owned in the Form 4 filed by the reporting person on December 27, 2022 in order to correct an inadvertent administrative error in such prior Form 4.